查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1456976

全球医疗保健外骨骼市场 - 预测 2024-2029

Global Healthcare Exoskeleton Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 103 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

医疗保健外骨骼市场预计将从 2022 年的 332,149,000 美元增加到 2029 年的 1,695,912,000 美元，预测期内复合年增长率为 26.23%。

电化学穿戴设备，通常称为医疗外骨骼，是作为支持系统而创建的，用于帮助固定患者从损伤中恢復并恢復独立或完全瘫痪的下肢的运动功能。医疗外骨骼可有效提升步行和恢復运动功能等生物能力。矫正器具等各种小工具也都很有用。这些穿戴式装置可以为患者提供行动性，甚至保险。医用外骨骼的存在可以让患有神经病变、脊髓损伤甚至瘫痪等身体残疾的人，包括老年人，过上更好的生活。

发展中国家越来越多地采用外骨骼，这将导致其需求在预测期内不断增加。此外，外骨骼市场的成长，包括此类设备的进步及其采用，被认为是该市场的一些关键驱动力。例如，在 2020 年，所谓的医疗保健公司 GenElex Technologies 有效地研究了这种外部佩戴设备，可以为中风、脊髓损伤甚至瘫痪患者提供支援。同样，ReWalk 还与德国保险公司 TK 和 DAK-Gesundheit 签署了几份合同，为脊髓损伤患者提供机器人外骨骼的有效承保。然而，在这方面，产品发布和相关成本几乎没有严格的监管核准。

市场驱动因素：

  • 身障者和整形外科手术的增加

整形外科手术的兴起预计将推动医疗保健外骨骼市场的成长。这是由于更换膝关节或髋关节所需的手术所致。此外，全球患有某种形式身体残疾的患者数量不断增加，包括医疗外骨骼保险覆盖范围的扩大，预计将成为加速市场成长的因素。例如，根据世界卫生组织 (WHO) 2022 年发布的报告，全球估计有 13 亿人，即每 6 人中就有 1 人患有严重残疾。

由于交通事故和各种疾病造成的损伤和伤害，需要各种肢体截肢。据报道，患坏疽的糖尿病患者截肢率也有所增加。此外，数量的增加对市场成长产生了积极作用。根据英国公共卫生局国家心血管情报网发布的糖尿病足部护理概况的资料，下肢截肢率持续上升。

由于上述原因，医疗外骨骼的采用不断增加。随着对有效復健方法的需求不断增加，外骨骼设备的进步被认为是进一步加速市场成长的另一个成长要素。这包括使用新的、先进的技术和产品，这些技术和产品很快​​就会推动医疗保健外骨骼的发展，从而加速医疗保健外骨骼的成长。

  • 对有效復健方法的需求不断增加

全球对高效復健技术（包括新颖、尖端产品和技术的应用）的需求正在不断增长。预计这将推动医疗外骨骼市场在所有重要地区的扩张。因此，它会影响整个预测期内的市场动态。

此外，随着身体缺陷人数的增加，医疗外骨骼市场将显着发展。由于老年人口增加以及一些国家推出医疗外骨骼保险等原因，医疗外骨骼市场正在加速扩张。此外，严重伤害、中风和道路事故发生频率的增加可能会加快市场开拓的步伐。

预计北美将占据大部分市场占有率

据说北美在医疗保健外骨骼市场中占有重要份额。不仅如此，中风和慢性病的盛行率不断增加，復健中心的增加，住院率的需求，处方笺的增加，政府拨款的增加，包括主要医疗费用的增加，最后是技术的发展意识的提高被认为是推动北美医疗外骨骼市场强劲成长的主要原因。主要医疗外骨骼製造商的强大存在也是医疗外骨骼在北美广泛采用的原因之一。

同时，亚太地区也因越来越多的外骨骼开发商而受到认可，他们高效、积极地以可承受的成本参与开发创新的医疗外骨骼。由于中风盛行率增加、人口老化加剧、相关健康状况、有利的政府政策以及医疗保健支出增加是推动市场的一些因素，亚太地区预计将以有利的速度增长。事实确实如此。根据联合国亚洲及太平洋经济社会委员会（ESCAP）统计，亚太地区人口老化速度比世界上任何其他地区都要快，预计到2050年这一数字将增加至13亿。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • CXO观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球医疗保健外骨骼市场：按类型

  • 介绍
  • 动力外骨骼
    • 市场机会和趋势
    • 成长前景
  • 被动外骨骼
    • 市场机会和趋势
    • 成长前景

第六章全球医疗保健外骨骼市场：按局部

  • 介绍
  • 下肢
    • 市场机会和趋势
    • 成长前景
  • 上端
    • 市场机会和趋势
    • 成长前景

第七章全球医疗保健外骨骼市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 其他的
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 台湾
    • 泰国
    • 印尼
    • 其他的

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 有竞争力的仪表板

第九章 公司简介

  • Rex Bionics Ltd.
  • ReWalk Robotics
  • Ekso Bionics
  • MARSI BIONICS, SL
  • B-Temia Inc.
  • Hocom
  • Myomo Inc
  • Honda Motor Co., Ltd.
简介目录
Product Code: KSI061612298

The global healthcare exoskeleton market is projected to grow at a CAGR of 26.23% during the forecast period to reach US$1,695.912 million in 2029 from US$332.149 million in 2022.

An electrochemical wearable device is commonly known as a medical exoskeleton which was created as a support system for patients in helping them with mobility difficulties to recover from their injuries and their motor functions in their party or even fully paralyzed lower extremities. The healthcare exoskeleton is efficient in improving biological abilities such as helping people to walk again or gain their motor function. There are various gadgets such as orthotic devices which are also beneficial. These wearable gadgets allow the patient to gain mobility strength and even insurance. Those individuals living with physical disabilities such as neurological disorders, spinal cord injuries, and even paralysis including elderly individuals live better due to the presence of medical exoskeletons.

The rising adoption of exoskeletons in developing countries will result in adding to their demand over the projected period. Furthermore, the increase in the market of exoskeletons including advancements and their adoption of such devices is regarded to be a few major driving forces for this market. For instance, in 2020, GenElex Technologies, which is regarded to be a healthcare firm efficiently worked on the external wearing of this device which can support people with stroke, spinal cord injury, and even paralysis. Similarly, ReWalk has entered into a few agreements with insurers TK and DAK-Gesundheit in Germany to provide effective coverage of robotic exoskeletons for individuals suffering from spinal cord injuries. However, in this regard, there are few stringent regulatory approvals for product launches and the costs associated with them.

MARKET DRIVER:

  • An increasing number of people with physical disabilities and orthopedic surgeries

The increase in the number of orthopedic surgeries is expected to drive the healthcare exoskeleton market toward growth. This is due to the operation necessary for knee and hip joint replacements. Moreover, the increasing number of patients suffering from some form of physical disability across the globe including the growing insurance coverage for the healthcare exoskeleton is a factor that is expected to accelerate the growth of the market. For example, according to the report published by the World Health Organization in 2022, an estimated 1.3 billion people or 1 in 6 people worldwide experience significant disability.

Various amputations of limbs have been performed which is due to the number of damages and injuries caused by multiple road accidents or even by various diseases. A rise in such amputation operations has been reported in those patients with diabetes who have also developed gangrene. Moreover, this rising number is positively favoring the growth of the market. Data from Diabetes Foot Care Profiles, published by PHEs National Cardiovascular Intelligence Network indicates that lower limb amputations continue to rise.

Due to the above reasons, the market continues to witness an increase in the adoption of healthcare exoskeletons. The advancements of exoskeleton devices which further will accelerate the growth of the market followed by a growing demand for effective rehabilitation approaches are regarded to be another growth factor. This includes the use of new and advanced technologies and products that have prompted the development of the healthcare exoskeleton, thereby driving the growth of healthcare exoskeleton shortly.

  • Increasing demand for efficient methods of rehabilitation

The demand for efficient rehabilitation techniques, including the application of novel and cutting-edge goods and technologies, is growing on a global scale. This is seen as encouraging for the medical exoskeleton market's expansion in all important regions. Influence market dynamics as a result throughout the projected term.

In addition, the market for medical exoskeletons will develop significantly as the number of persons with physical limitations rises. The medical exoskeleton market is expanding at an accelerated rate due to reasons such as the growing senior population and the increased availability of medical exoskeleton insurance coverage in several nations. In addition, a rise in the frequency of serious injuries, strokes, and traffic accidents will accelerate the market's development pace.

North America is anticipated to hold a significant amount of the market share

North America is said to hold a significant amount of market share for the market of healthcare exoskeleton. Not only this but the prevalence of increasing strokes, and chronic illness, followed by the increase in the number of rehabilitation centers, the demand in hospitalization rates, rise in prescriptions, increasing funding by the government including the key healthcare expenditure, and lastly the growing awareness of technological developments are regarded to be major reasons which are imperatively driving North American healthcare exoskeleton market towards growth. The strong presence of key medical exoskeleton players is also another reason for the high uptake of the medical exoskeleton in North America.

On the other hand, APAC is also regarded to account for a growing number of exoskeleton developers who are efficiently and actively involved in the development of innovative medical exoskeletons at affordable costs. APAC is projected to grow at a lucrative rate due to an increase in stroke incidence, a growing aging population, related health conditions, favorable government policies, and increasing healthcare expenditures are some of the factors driving the market. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the Asia-Pacific population is aging faster than any other region in the world as by 2050, the number is projected to increase to 1.3 billion.

Market Key Developments

  • August 2023- ReWalk Robotics has announced a definitive agreement to acquire AlterG, a leading provider of Anti-Gravity systems for physical and neurological rehabilitation. The acquisition will expand ReWalk's neurorehabilitation product portfolio and add AlterG's current and future product lines. The deal is expected to significantly expand ReWalk's customer-facing capabilities and advance future growth opportunities. AlterG is a leader in transformative technology that empowers people to recover mobility, improve wellness, and enhance physical performance.

Segmentation:

By Type

  • Powered Exoskeleton
  • Passive Exoskeleton

By Extremity

  • Lower Extremity
  • Upper Extremity

By Geography

  • North America
  • USA
  • Canada
  • Others
  • South America
  • Brazil
  • Others
  • Europe
  • Germany
  • UK
  • France
  • Others
  • Middle East and Africa
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL HEALTHCARE EXOSKELETON MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Powered Exoskeleton
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
  • 5.3. Passive Exoskeleton
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects

6. GLOBAL HEALTHCARE EXOSKELETON MARKET, BY EXTREMITY

  • 6.1. Introduction
  • 6.2. Lower Extremity
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
  • 6.3. Upper Extremity
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects

7. GLOBAL HEALTHCARE EXOSKELETON MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. United States
      • 7.2.1.1. Market Opportunities and Trends
      • 7.2.1.2. Growth Prospects
    • 7.2.2. Canada
      • 7.2.2.1. Market Opportunities and Trends
      • 7.2.2.2. Growth Prospects
    • 7.2.3. Mexico
      • 7.2.3.1. Market Opportunities and Trends
      • 7.2.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. Brazil
      • 7.3.1.1. Market Opportunities and Trends
      • 7.3.1.2. Growth Prospects
    • 7.3.2. Argentina
      • 7.3.2.1. Market Opportunities and Trends
      • 7.3.2.2. Growth Prospects
    • 7.3.3. Others
      • 7.3.3.1. Market Opportunities and Trends
      • 7.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. United Kingdom
      • 7.4.1.1. Market Opportunities and Trends
      • 7.4.1.2. Growth Prospects
    • 7.4.2. Germany
      • 7.4.2.1. Market Opportunities and Trends
      • 7.4.2.2. Growth Prospects
    • 7.4.3. France
      • 7.4.3.1. Market Opportunities and Trends
      • 7.4.3.2. Growth Prospects
    • 7.4.4. Italy
      • 7.4.4.1. Market Opportunities and Trends
      • 7.4.4.2. Growth Prospects
    • 7.4.5. Spain
      • 7.4.5.1. Market Opportunities and Trends
      • 7.4.5.2. Growth Prospects
    • 7.4.6. Others
      • 7.4.6.1. Market Opportunities and Trends
      • 7.4.6.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. Saudi Arabia
      • 7.5.1.1. Market Opportunities and Trends
      • 7.5.1.2. Growth Prospects
    • 7.5.2. UAE
      • 7.5.2.1. Market Opportunities and Trends
      • 7.5.2.2. Growth Prospects
    • 7.5.3. Others
      • 7.5.3.1. Market Opportunities and Trends
      • 7.5.3.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Market Opportunities and Trends
      • 7.6.1.2. Growth Prospects
    • 7.6.2. China
      • 7.6.2.1. Market Opportunities and Trends
      • 7.6.2.2. Growth Prospects
    • 7.6.3. India
      • 7.6.3.1. Market Opportunities and Trends
      • 7.6.3.2. Growth Prospects
    • 7.6.4. South Korea
      • 7.6.4.1. Market Opportunities and Trends
      • 7.6.4.2. Growth Prospects
    • 7.6.5. Taiwan
      • 7.6.5.1. Market Opportunities and Trends
      • 7.6.5.2. Growth Prospects
    • 7.6.6. Thailand
      • 7.6.6.1. Market Opportunities and Trends
      • 7.6.6.2. Growth Prospects
    • 7.6.7. Indonesia
      • 7.6.7.1. Market Opportunities and Trends
      • 7.6.7.2. Growth Prospects
    • 7.6.8. Others
      • 7.6.8.1. Market Opportunities and Trends
      • 7.6.8.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Rex Bionics Ltd.
  • 9.2. ReWalk Robotics
  • 9.3. Ekso Bionics
  • 9.4. MARSI BIONICS, S.L
  • 9.5. B-Temia Inc.
  • 9.6. Hocom
  • 9.7. Myomo Inc
  • 9.8. Honda Motor Co., Ltd.